Mirabella Financial Services’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,200,000
Closed -$12.7M 1086
2025
Q4
$12.7M Hold
8,200,000
1.18% 13
2025
Q3
$13M Buy
8,200,000
+1,600,000
+24% +$2.78M 1.12% 16
2025
Q2
$14.4M Sell
6,600,000
-800,000
-11% -$1.94M 1.48% 15
2025
Q1
$20.2M Buy
7,400,000
+3,700,000
+100% +$14.6M 0.41% 50
2024
Q4
$15.4M Buy
+3,700,000
New +$14M 1.4% 12

Other funds holding MXCT

Mirabella Financial Services's MXCT Position: Q1 2026 in Review

Mirabella Financial Services sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 8,200,000 shares — an estimated $12.7M sold.

Mirabella Financial Services first reported a position in MXCT in Q4 2024 and held it in 5 quarters. The position peaked at $20.2M in Q1 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Mirabella Financial Services reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 8,200,000 MaxCyte shares in Q1 2026, an estimated $12.7M.
  • Mirabella Financial Services first reported a position in MaxCyte in Q4 2024 and held it in 5 quarters.
  • Mirabella Financial Services's MaxCyte position peaked at $20.2M in Q1 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Mirabella Financial Services's 13F filing for Q1 2026, filed 12 May 2026.